$PGEN

$6.16 +$0.12 (1.9%) Live

$PGEN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 358.0M shares outstanding

Who owns PGEN?

By type of holder

Institutions 39.0% Insiders 61.0% Everyone else 0.0%

Concentration Top 10 holders own 60.7%

Randal J. Kirk 37.4% · Patient Capital Management, LLC 5.3%

Institutional ownership

39.0%

+1.7 pts vs last qtr

Institutional holders

208

+2 vs last qtr

Net shares bought

+6.0M

by institutions in Q2 2026

New / sold out

35 / 33

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Diametric Capital, LP +2.5M
First Trust Advisors LP NEW +2.0M

Biggest sellers in Q2 2026

Point72 Asset Management, L.P. −5.4M
Citadel Advisors LLC −1.9M

Who is planning to sell?

Notices of proposed sale, last 12 months

$39.3M

11 notices from 6 people

Shares covered

9.7M

2.70% of the company

Arranged in advance

11%

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Randal J. Kirk Director $25.7M
Kirk Randal J Director $8.43M

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2019–FY2025

+103.1%

+12.53% a year

Each share's claim on the business

−50.8%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $91.7M

over 7 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years51% 3–5 years16% 1–3 years10% Under 1 year24%

Quarterly turnover

15.5%

of institutional shares changed hands

Top 10 managers, median time held

5 years

Super Investors

Investment managers reporting PGEN on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
PC Patient Capital Management, LLC	19.0M	5.32%	+1.2M (+6.8%)	2021	3.6%
Shares held by quarter Peak holding26.5M (Q3'25) Change over 8 quarters+1.1M Share of the company5.320% Patient Capital Management, LLC's full portfolio →
B BlackRock, Inc.	17.1M	4.79%	+1.9M (+12.6%)	≤2021	0.0%
Shares held by quarter Peak holding17.1M (Q2'26) Change over 8 quarters+6.8M Share of the company4.790% BlackRock, Inc.'s full portfolio →

Patient Capital Management, LLC

19.0M

% of company

5.32%

Change vs last qtr

+1.2M (+6.8%)

Held since

2021

BlackRock, Inc.

17.1M

% of company

4.79%

Change vs last qtr

+1.9M (+12.6%)

Held since

≤2021

28 more super investors behind a free account

See every manager holding Precigen, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting PGEN on Form N-PORT; together they hold 15.8% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
PO Patient Opportunity Trust Advisor Managed Portfolios	$73.5M	12.9M	3.60%	3.66%	June 30, 2026
SS State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR Series Trust	$40.4M	7.1M	1.98%	0.38%	June 30, 2026

Patient Opportunity Trust

Advisor Managed Portfolios

Position value

$73.5M

% of company

3.60%

% of the fund

3.66%

As of

June 30, 2026

State Street(R) SPDR(R) S&P(R) Biotech ETF

SPDR Series Trust

Position value

$40.4M

% of company

1.98%

% of the fund

0.38%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Precigen, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
RJ Randal J. Kirk 5%+ holder 13D · 35.9%	134.0M	37.41%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company37.410% Disclosed stake13D · 35.9% View the 13D/G filing →
SH Sabzevari Helen Insider	3.8M	1.06%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company1.060% Sabzevari Helen's insider activity →

Randal J. Kirk

5%+ holder13D · 35.9%

134.0M

% of company

37.41%

Change vs last qtr

—

Held since

—

Sabzevari Helen

Insider

3.8M

% of company

1.06%

Change vs last qtr

—

Held since

—

11 more holders behind a free account

See every insider and 5%+ holder of Precigen, Inc..

Comments